Streetbeat News

Partnerships

NVEI

ViaPlus, a subsidiary of VINCI Highways, has partnered with Nuvei Corporation to enhance payment experiences for mobility services. This partnership will offer over 700 new types of payments in 150+ currencies, benefiting consumers and transportation agencies in countries like Brazil, Peru, and Colombia.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:10 pm

MYGN

Myriad Genetics has announced a collaboration with GSK to enhance access to homologous recombination deficiency (HRD) testing in nine countries. This partnership aims to improve the availability and accuracy of HRD testing, which is crucial for identifying patients who may benefit from targeted therapies.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:07 pm

NVDA

ZS

Zscaler has announced a collaboration with NVIDIA to accelerate AI-powered copilot technologies, aiming to enhance user experience and security-centric services for enterprises.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:06 pm

ACN

BK

Bank of New York Mellon (NYSE:BK) is rebranding to BNY, focusing on growth areas like real-time payments and AI. The bank has reported strong financial results and a 17% stock rise in 2024. A collaboration with Accenture aims to modernize financial services.

Portfolio Pulse from Benzinga Neuro

June 11, 2024 | 12:05 pm

IONQ

IonQ (NYSE:IONQ) and South Carolina Quantum (SCQ) have launched a Faculty & Researcher Learning Series to introduce quantum technologies to academia. Clemson University will be the first to integrate this series, offering free sessions to faculty and researchers.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:05 pm

TAK

Takeda has expanded its partnership with Partners In Health to address social determinants of health and improve access to care in Massachusetts. The initiative aims to dismantle systemic barriers to equity and strengthen the health workforce in the state. The existing global partnership has already provided screening and diagnostic services to over 8 million people in community settings.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:02 pm

SXTP

60 Degrees Pharmaceuticals has received FDA Orphan Drug Designation for tafenoquine to treat acute babesiosis. This designation provides incentives like market exclusivity, tax credits, and fee exemptions. The company has also partnered with Tufts Medical Center to conduct a clinical trial for tafenoquine's efficacy and safety in treating human babesiosis.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 12:00 pm

COST

FTXR

GM

RPV

General Motors (GM) has announced a new $6 billion stock buyback program, leading to a premarket increase in its share price. The company has a history of share repurchases and recently increased its dividend. GM is also leveraging its partnership with Costco to expand its EV portfolio. The stock has gained over 29% in the past year.

Portfolio Pulse from Nabaparna Bhattacharya

June 11, 2024 | 11:58 am

ZBH

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has announced a limited distribution agreement with THINK Surgical, Inc. to offer the TMINI Miniature Handheld Robotic System for total knee arthroplasty. This agreement will integrate Zimmer Biomet technology into a customized TMINI robotic solution, complementing its ROSA® Robotics portfolio.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 11:33 am

MNPR

Monopar Therapeutics and NorthStar Medical Radioisotopes have announced an amendment and extension to their existing collaboration. This extension aims to further their joint development of radio-immuno-therapeutics for cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

June 11, 2024 | 11:32 am